Female Urinary Incontinence Treatment Device Market
Added: (Thu Jan 06 2022)
Pressbox (Press Release) -
Market Overview
The Global Female Urinary Incontinence Treatment Device Market is expected to grow at a CAGR during the forecasting period (2021-2028).
Female urinary incontinence has been diagnosed as a condition that causes involuntary urination. Urinary incontinence or stress urinary incontinence typically occurs during physical activities, such as sneezing, coughing, running, or even during weightlifting, as these activities exert pressure on the urinary bladder. Urinary urge and stress incontinence are different, as the former occurs when the bladder muscles are contracted. Urinary stress incontinence affects women more than men and is mostly due to weak muscle sphincter, which can lead to social isolation. Female urinary incontinence is of two types: the first is urethral hypermobility and the second is due to an inherent sphincter deficiency. In the case of urethra hypermobility, increased abdominal pressure changes the position of the urethra. On the other hand, in the inherent sphincter of the deficiency, the sphincter has lost its ability to seal the deficiency of the intestinal sphincter.
Get Free Sample : https://www.datamintelligence.com/download-sample/female-urinary-incontinence-treatment-device-market
Market Dynamics
The major factors propelling the growth of the female urinary incontinence treatment device market are the rising prevalence of urinary incontinence in pregnant women, stress urinary incontinence due to diabetes, gynecology disorders, and urinary incontinence in postmenopausal women and rising cases of hysterectomy. Moreover, the rising incidence of obesity in the female population is the major factor expected to deliver significant growth to the market in the upcoming period.
Rising prevalence of urinary incontinence in pregnant women
According to the National Center for Biotechnology Information, the prevalence of urinary incontinence during pregnancy in 750 was 300. (40 per cent). Stress urinary incontinence was the most common type of incontinence in pregnancy. 41.7 per cent of nulliparous women, 38 per cent of primipara women and 20.3 per cent of multi parallel women experienced urinary incontinence. Among women reporting UI, 29.3 per cent experienced leakage a few times a day, and the amount of leakage was generally moderate (59.7 per cent). Factors significantly associated with urinary incontinence included age group, gestational age, parity, prior urinary incontinence, constipation, last childbirth mode of delivery, previous urinary tract infection, body mass index during pregnancy.
Increase in the penetration of private-label brands at much lower prices
Due to the presence of a wide range of products on the market for female stress urinary incontinence treatment devices, small players are gaining interest and selling their products at a lower price. An increase in the penetration of private-label brands at much lower prices is expected to reduce the average overall price of female urinary incontinence stress treatment devices. This is likely to constrain the growth of the global market for female stress urinary incontinence treatment devices, as it is likely to hinder demand for expensive products.
View Full Report : https://www.datamintelligence.com/research-report/female-urinary-incontinence-treatment-device-market#
COVID-19 Impact Analysis
The outbreak of COVID-19 has negatively impacted the growth of the female urinary incontinence treatment device market globally. Restrictions on hospitals services have affected the specialised investigation and surgical management of patients with urinary incontinence. Therefore, the COVID-19 pandemic has driven the market value of the female urinary incontinence treatment device market in 2020.
Market Segmentation
Based on the product type, the female urinary incontinence treatment device market has been classified into urethral devices and internal vaginal devices
The internal vaginal device segment is projected to be the dominant segment in the market during the forecast period.
The internal vaginal devices segment can be further categorized into traditional devices and custom-made devices. Urinary stress incontinence is significantly more common in women than in men. Female urinary incontinence treatment device occurs when pelvic floor muscles or urinary sphincter are likely to lose strength, either due to women's childbirth or men's prostate surgery. Thus, due to such factors, the internal vaginal device is expected to hold a dominant position in the market.
The female urinary incontinence treatment device is segmented based on end-user, which includes hospitals, speciality clinics, and ambulatory surgical centers.
Hospitals pharmacies are expected to dominate the Female Urinary Incontinence Treatment Device market.
Hospital in the end-user segment is expected to have a significant share of the global market for urinary incontinence devices due to the large patient population treated in hospitals suffering from urinary incontinence. Moreover, hospitals are also expected to grow with the highest CAGR in the forthcoming period with the rise in technological advancement in the industry.
Furthermore, the female urinary incontinence treatment device is segmented on the basis of material used, which includes polyurethane foam and silicone. Polyurethane foam is the dominating segment along with projected to grow with the highest CAGR in the forthcoming period.
Geographical Analysis
Based on geography, the study analyzes the female urinary incontinence treatment device market in the global market, including North America, Europe, Asia-Pacific, South America, and the Middle East & Africa.
North America is expected to dominate the global female urinary incontinence treatment device market.
North America is holding a dominant position in the global female urinary incontinence treatment device market in 2019. In North America, the U.S. is expected to represent considerable growth during the forecast period. In the U.S., the female urinary incontinence treatment device is expected to have potential growth due to the rising prevalence of urinary incontinence in pregnant women, and stress urinary incontinence due to diabetes, gynecology disorders, and urinary incontinence in postmenopausal women. The Asia-Pacific market is projected to expand significantly during the forecast period due to increased awareness, increased investment in health care to provide optimum facilities at affordable cost, and socio-economic development. The increase in the number of women smoking in China is expected to boost the market. Increased investment by prominent players in developing countries is expected to boost the market. The Middle East & Africa market is projected to expand at a slow pace due to lack of awareness, low disposable income, and limited healthcare facilities.
Competitive Landscape
The key female urinary incontinence treatment device market players which are contributing to the growth of the global market include are Karl Storz, Johnson & Johnson, Coloplast, Boston Scientific, Teleflex, American Medical Solutions, among others. The major players are adopting new product launch and expansion strategies for global growth in the female urinary incontinence treatment device market.
Altis Single Incision Sling (Coloplast):
The Altis single incision sling is an innovative next-generation Coloplast technology. Altis is both less invasive and less prone to implants; however, it is based on the proven product legacy of Aris TO and Supris RP Systems. The Altis Single Incision Sling System is indicated for adult women in the treatment of female urinary incontinence treatment device (SUI) due to urethral hypermobility and/or intestinal sphincter deficiency (ISD)
Product Portfolio: The Company’s portfolio comprises essential, Altis single incision sling, Surprise, Aris and Durasphere Exp and others
Enquiry Before Buying : https://www.datamintelligence.com/enquiry/female-urinary-incontinence-treatment-device-market
Sai Kiran
Sales Manager at Data M Intelligence
Email: info@datamintelligence.com
Tel: +1 877 441 4866
Website: www.datamintelligence.com